Cited by 43Retinal Diseases and TreatmentsPeroxisome Proliferator-Activated ReceptorsRetinal Development and Disorders

Peroxisome proliferator-activated receptor and age-related macular degeneration

Open access
Herzlich, Alexandra A., Tuo, Jingsheng, Chan, Chi-Chao·2008·PPAR Research

Abstract

Age-related macular degeneration (AMD) is the leading cause of new blindness in the western world and is becoming more of a socio-medical problem as the proportion of the aged population increases. There are multiple efforts underway to better understand this disease process. AMD involves the abnormal retinal pigment epithelium (RPE), drusen formation, photoreceptor atrophy, and choroidal neovascularization. Peroxisome proliferator-activated receptors (PPARs) play an important role in lipid degeneration, immune regulation, regulation of reactive oxygen species (ROSs), as well as regulation of vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and docosahexaenoic acid (DHA). These molecules have all been implicated in the pathogenesis of AMD. In addition, PPAR gamma is expressed in RPE, an essential cell in photoreceptor regeneration and vision maintenance. This review summarizes the interactions between PPAR, AMD-related molecules, and AMD-related disease processes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2008/389507

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The Ccl2−/−/Cx3cr1−/− mouse model demonstrates many AMD features: small drusenoid deposits, RPE and Bruch's membrane degenerations, photoreceptor atrophy, CNV, and simulation of the immunologic and pathologic environments found in AMD patients.

    “The Ccl2−/−/Cx3cr1−/− mouse model demonstrates many AMD features: small drusenoid deposits, RPE and Bruch’s membrane degenerations, photoreceptor atrophy, CNV, and simulation of the immunologic and pathologic environments found in AMD patients (Herzlich et al., 2008; Ross et al., 2008; Ding et al., 2009).”

    From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Herzlich et al., 2008

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 120 · Cited by 43

Research works printed but not linked: 2

  1. [91]Hageman GS Anderson DH Johnson LV A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration Proceedings of the National Academy of Sciences of the United States of America 2005 102 20 7227 7232 15870199 PMC1088171
  2. [93]Hageman GS Luthert PJ Victor Chong NH Johnson LV Anderson DH Mullins RF An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration Progress in Retinal and Eye Research 2001 20 6 705 732 11587915

Authors
Herzlich, A. A., Tuo, J., & Chan, C.-C.
Affiliations
National Institutes of Health (US)
Corresponding author
Chan, Chi-Chao
Venue
PPAR Research
Publisher
Wiley
Published
2008-01
Volume
2008
Issue
1
Pages
389507-389507
ISSN
  • 1687-4757 (ISSN-L)
  • 1687-4765
OpenAlex
W2034826672
Cited by
43
References
120
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 1 · 2017: 2 · 2016: 3 · 2015: 5 · 2014: 2 · 2013: 2 · 2012: 5
FWCI
3.71
Type
journal article
Language
en
Open access
Locations
  • PPAR Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
Keywords
age-related macular degeneration, peroxisome proliferator-activated receptors, PPARγ, retinal pigment epithelium, drusen formation, photoreceptor atrophy, choroidal neovascularization, reactive oxygen species, vascular endothelial growth factor, MMP-9, docosahexaenoic acid, immune regulation, photoreceptor regeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review